Dinesh Kumar Verma

About

I am a neuroscientist with over 12 years of research experience in neurobiology, molecular and cellular neuroscience, with a strong focus on neurodegenerative diseases. My work has contributed to understanding the mechanisms of cellular senescence, protein aggregation, and neuroinflammation in Parkinson’s Disease, as well as identifying potential therapeutic targets. I have held research and teaching positions at Delaware State University, university of Minnesota and Boise State University, where I mentor students and integrate cutting-edge neuroscience research into education. Passionate about scientific discovery and mentorship, I strive to foster an engaging and inclusive learning environment while advancing translational neuroscience research.

Employment

• Boise State University Research Assistant Professor
  2025 - Present
• Boise State University Research Associate
  2024 - 2025
• Delaware State University Post Doc Associate/Instructor
  2022 - 2024
• University of Minnesota, Twin Cities Postdoc Research Associate
  2021 - 2022
• Delaware State University Post Doc Fellow
  2018 - 2021
• Directorate of Plant Protection Quarantine and Storage Consultant (Toxicology)
  2018 - 2018
• Directorate of Plant Protection Quarantine and Storage Research Officer
  2017 - 2018

Education

• Jawaharlal Nehru University Ph.D. (Neuroscience)
  2012 - 2017
• Babasaheb Bhimrao Ambedkar University School of Life Sciences Masters in Science (MSc)
  2009 - 2011
• Chhatrapati Shahu Ji Maharaj University Bachelor in Science (BSc)
  2006 - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (16)

• A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice
  International Journal of Molecular Sciences 2023 DOI: 10.3390/ijms241814278
  +Save
• The combination of violet light and infra-red as well as violet light only effectively suppress the survival of multiple-drug resistant bacteria
  Journal of Photochemistry and Photobiology 2023 DOI: 10.1016/j.jpap.2023.100167
  +Save
• A Novel NOX Inhibitor Treatment Attenuates Parkinson’s Disease-Related Pathology in Mouse Models
  International Journal of Molecular Sciences 2022 DOI: 10.3390/ijms23084262
  +Save
• Correction to: Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase Independent Pathway, Poly [ADP-ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation (Neurotoxicity Research, (2018), 34, …
  Neurotoxicity Research 2022 DOI: 10.1007/s12640-022-00471-0
  +Save
• Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson’s Disease Models
  Cells 2021 DOI: 10.3390/cells10071694
  +Save
• The SUMO conjugase Ubc9 protects Dopaminergic cells from cytotoxicity and enhances the stability of α-synuclein in Parkinson's disease models.
  eNeuro 2020 DOI: 10.1523/eneuro.0134-20.2020
  +Save
• New therapeutic activity of metabolic enhancer piracetam in treatment of neurodegenerative disease: Participation of caspase independent death factors, oxidative stress, inflammatory responses and apoptosis.
  Biochimica et biophysica acta. Molecular basis of disease 2018 DOI: 10.1016/j.bbadis.2018.03.014
  +Save
• Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation.
  Neurotoxicity research 2018 DOI: 10.1007/s12640-018-9878-2
  +Save
• Minocycline diminishes the rotenone induced neurotoxicity and glial activation via suppression of apoptosis, nitrite levels and oxidative stress.
  Neurotoxicology 2018 DOI: 10.1016/j.neuro.2018.01.006
  +Save
• Involvement of glucose related energy crisis and endoplasmic reticulum stress: Insinuation of streptozotocin induced Alzheimer's like pathology.
  Cellular signalling 2017 DOI: 10.1016/j.cellsig.2017.10.018
  +Save